The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Neurologic Manifestations in Primary Sjögren Syndrome: A Study of 82 Patients
Abstract
Neurologic involvement occurs in approximately 20% of patients with primary Sjögren syndrome (SS). However, the diagnosis of SS with neurologic involvement is sometimes difficult, and central nervous system (CNS) manifestations have been described rarely. We conducted the current study to describe the clinical and laboratory features of SS patients with neurologic manifestations and to report their clinical outcome. We retrospectively studied 82 patients (65 women and 17 men) with neurologic manifestations associated with primary SS, as defined by the 2002 American-European criteria. The mean age at neurologic onset was 53 years. Neurologic involvement frequently preceded the diagnosis of SS (81% of patients). Fifty-six patients had CNS disorders, which were mostly focal or multifocal. Twenty-nine patients had spinal cord involvement (acute myelopathy [n = 12], chronic myelopathy [n = 16], or motor neuron disease [n = 1]). Thirty-three patients had brain involvement and 13 patients had optic neuropathy. The disease mimicked relapsing-remitting multiple sclerosis (MS) in 10 patients and primary progressive MS in 13 patients. We also recorded diffuse CNS symptoms: some of the patients presented seizures (n = 7), cognitive dysfunction (n = 9), and encephalopathy (n = 2). Fifty-one patients had peripheral nervous system involvement (PNS). Symmetric axonal sensorimotor polyneuropathy with a predominance of sensory symptoms or pure sensory neuropathy occurred most frequently (n = 28), followed by cranial nerve involvement affecting trigeminal, facial, or cochlear nerves (n = 16). Multiple mononeuropathy (n = 7), myositis (n = 2), and polyradiculoneuropathy (n = 1) were also observed. Thirty percent of patients (all with CNS involvement) had oligoclonal bands. Visual evoked potentials were abnormal in 61% of the patients tested. Fifty-eight patients had magnetic resonance imaging (MRI) of the brain. Of these, 70% presented white matter lesions and 40% met the radiologic criteria for MS. Thirty-nine patients had a spinal cord MRI. Abnormalities were observed only in patients with spinal cord involvement. Among the 29 patients with myelopathy, 75% had T2-weighted hyperintensities. Patients with PNS manifestations had frequent extraglandular complications of SS. Anti-Ro/SSA or anti-La/SSB antibodies were detected in 21% of patients at the diagnosis of SS and in 43% of patients during the follow-up (mean follow-up, 10 yr). Biologic abnormalities were more frequently observed in patients with PNS involvement than in those with CNS involvement (p < 0.01). Fifty-two percent of patients had severe disability, and were more likely to have CNS involvement than PNS involvement (p < 0.001). Treatment by cyclophosphamide allowed a partial recovery or stabilization in patients with myelopathy (92%) or multiple mononeuropathy (100%). The current study underlines the diversity of neurologic complications of SS. The frequency of neurologic manifestations revealing SS and of negative biologic features, especially in the event of CNS involvement, could explain why SS is frequently misdiagnosed. Screening for SS should be systematically performed in cases of acute or chronic myelopathy, axonal sensorimotor neuropathy, or cranial nerve involvement. The outcome is frequently severe, especially in patients with CNS involvement. Our study also underlines the efficacy of cyclophosphamide in myelopathy and multiple neuropathy occurring during SS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E., Fox, P. C., Fox, R. I., Kassan, S. S., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.554 · Cited by 5,299
Labial salivary gland biopsy in Sjögren's disease
Chisholm, D. M., & Mason, D. K. (1968) · Journal of Clinical Pathology · doi:10.1136/jcp.21.5.656 · Cited by 1,017
Bamford, J., Sandercock, P., Dennis, M., Warlow, C., Jones, L., McPherson, K., Vessey, M., Fowler, G., Molyneux, A., & Hughes, T. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.11.1373 · Cited by 470
Primary Sjögren Syndrome: Clinical and Immunologic Disease Patterns in a Cohort of 400 Patients
GARCÍA-CARRASCO, M., RAMOS-CASALS, M., ROSAS, J., PALLARÉS, L., CALVO-ALEN, J., CERVERA, R., FONT, J., & INGELMO, M. (2002) · Medicine · doi:10.1097/00005792-200207000-00003 · Cited by 443
Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome
Griffin, J. W., Cornblath, D. R., Alexander, E. L., Campbell, J., Low, P. A., Bird, S. J., & Feldman, E. L. (1990) · Annals of Neurology · doi:10.1002/ana.410270313 · Cited by 389
Primary Sjögren's Syndrome with Central Nervous System Disease Mimicking Multiple Sclerosis
ALEXANDER, E. L., MALINOW, K., LEJEWSKI, J. E., JERDAN, M. S., PROVOST, T. T., & ALEXANDER, G. E. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-3-323 · Cited by 253
Neurological complications of primary Sjögren's syndrome
Lafitte, C., Amoura, Z., Cacoub, P., Pradat-Diehl, P., Picq, C., Salachas, F., Léger, J. M., Piette, J. C., & Delattre, J. Y. (2001) · Journal of Neurology · doi:10.1007/s004150170135 · Cited by 184
Peripheral neuropathy associated with sicca complex
Grant, I. A., Hunder, G. G., Homburger, H. A., & Dyck, P. J. (1997) · Neurology · doi:10.1212/wnl.48.4.855 · Cited by 183
Acute Transverse Myelopathy in Adults: A Follow-Up Study
Lipton, H. L. (1973) · Archives of Neurology · doi:10.1001/archneur.1973.00490220060009 · Cited by 161
Alexander, E. L., Ranzenbach, M. R., Kumar, A. J., Kozachuk, W. E., Rosenbaum, A. E., Patronas, N., Harley, J. B., & Reichlin, M. (1994) · Neurology · doi:10.1212/wnl.44.5.899 · Cited by 154
Cited by
Jarius, S., Paul, F., Franciotta, D., Ruprecht, K., Ringelstein, M., Bergamaschi, R., Rommer, P., Kleiter, I., Stich, O., Reuss, R., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.038 · Cited by 361
Cervical Spondylotic Myelopathy
Tracy, J. A., & Bartleson, J. D. (2010) · The Neurologist · doi:10.1097/nrl.0b013e3181da3a29 · Cited by 321
The Emerging Link Between Autoimmune Disorders and Neuropsychiatric Disease
Kayser, M. S., & Dalmau, J. (2011) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.23.1.90 · Cited by 133
Harboe, E., Tjensvoll, A. B., Maroni, S., Gøransson, L. G., Greve, O. J., Beyer, M. K., Herigstad, A., Kvaløy, J. T., & Omdal, R. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.098301 · Cited by 124
Overview of treatment of pediatric acute-onset neuropsychiatric syndrome
Swedo, S. E., Frankovich, J., & Murphy, T. K. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0042 · Cited by 104
Metadata
- Authors
- Delalande, S., de Seze, J., Fauchais, A.-L., Hachulla, E., Stojkovic, T., Ferriby, D., Dubucquoi, S., Pruvo, J.-P., Vermersch, P., & Hatron, P.-Y.
- Venue
- Medicine
- Published
- 2004-09
- Volume
- 83
- Issue
- 5
- Pages
- 280-291
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2083149517
- Cited by
- 647
- References
- 16
- FWCI
- 10.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurologic Manifestations in Primary Sjögren Syndrome: A Study of 82 Patients. https://app.cochat.ai/papers/10.1097/01.md.0000141099.53742.16
- The paper
- Delalande, S., de Seze, J., Fauchais, A.-L., Hachulla, E., Stojkovic, T., Ferriby, D., Dubucquoi, S., Pruvo, J.-P., Vermersch, P., & Hatron, P.-Y. (2004). Neurologic Manifestations in Primary Sjögren Syndrome: A Study of 82 Patients. Medicine. https://doi.org/10.1097/01.md.0000141099.53742.16
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.